NEW YORK - Nov. 22, 2000 – Micromass is investing $7.5 million in Montreal-based Caprion Pharmaceuticals’ new proteomics effort, and is setting up a network of its mass spectrometry machines at Caprion’s new proteomics facility, the companies announced Tuesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.